Dublin, Jan. 08, 2026 (GLOBE NEWSWIRE) — The “Brain Tumor Therapeutics: Global Markets to 2030” has been added to ResearchAndMarkets.com’s offering.
This report on brain tumor therapeutics presents a comprehensive analysis of current market trends and future trajectories. Anchoring on 2024 as the base year, the report provides market estimates for 2025 and projections up to 2030. This study is segmented by therapy type, patient age, end user, and geographic regions, offering crucial insights into a highly dynamic field.
The report delves into various types of brain tumor therapies, including chemotherapy, targeted therapy, and immunotherapy, evaluating their impact on both adult and pediatric populations. The end user segment further classifies the market into hospitals and home care settings, underscoring a multifaceted approach in the treatment framework.
Regionally, the market analysis covers North America, Europe, Asia-Pacific, the Middle East and Africa, and South America, with detailed insights into significant markets such as the U.S., Canada, Germany, the UK, France, Italy, Spain, Japan, China, South Korea, Australia, and India. By incorporating detailed projections through 2030, stakeholders can uncover potential opportunities within these key markets.
Key Insights and Objectives:
- Provide a detailed analysis of different brain tumor treatments and their global market presence.
- Examine the market size, segmentation, and dynamics shaping the industry landscape.
- Identify constraints and drivers influencing market growth, with strategic forecasts till 2030.
- Explore market shares, competitiveness, and new industry structures arising from ongoing trends.
- Assess long-term impacts affecting the brain tumor therapeutics market trajectory.
Report Highlights Include:
- Analytical overview of historical data and forecasted market trends from 2024 through 2030, predicting compound annual growth rates.
- In-depth market segmentation analysis by therapy type, age group, end user, and region.
- Evaluation of technological advancements, regulatory impacts, and macroeconomic variables influencing market dynamics.
- Impact assessment of U.S. tariff laws and case studies on AI integration in therapeutic strategies.
- Leveraging Porter’s Five Forces, global supply chain, and PESTLE models for strategic insights.
- Sustainability and ESG trends focusing on consumer attitudes, alongside risk ratings and leading companies’ practices.
- Patent analysis spotlighting key intellectual properties that drive market innovation.
- Structural analysis of the industry, including market shares, strategic initiatives, mergers and acquisitions, and a venture capital outlook.
- Profiles of leading companies shaping the brain tumor therapeutics landscape.
This report is an indispensable resource for stakeholders aiming to understand and capitalize on the evolving brain tumor therapeutics market landscape, offering a roadmap to navigate future challenges and opportunities effectively.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 120 |
| Forecast Period | 2025-2030 |
| Estimated Market Value (USD) in 2025 | $2.5 Billion |
| Forecasted Market Value (USD) by 2030 | $4.7 Billion |
| Compound Annual Growth Rate | 11.1% |
| Regions Covered | Global |
Companies Featured
- Amgen Inc.
- Amneal Pharmaceuticals LLC
- Baxter
- Bayer AG
- F. Hoffmann-La Roche Ltd.
- Merck & Co. Inc.
- Novartis AG
- Pfizer Inc.
- Servier Laboratories
- Teva Pharmaceutical Industries Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/3s2w2l
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Global Brain Tumor Therapeutics Market
